home / stock / spro / spro articles

SPRO Articles, Spero Therapeutics Inc. - From 06/03/24

Stock Information
Company Name: Spero Therapeutics Inc.
Stock Symbol: SPRO
Market: NASDAQ
Website: sperotherapeutics.com
Menu
SPRO SPRO Quote SPRO Short SPRO News SPRO Articles SPRO Message Board
Get SPRO Alerts

News, Short Squeeze, Breakout and More Instantly...
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical comp...
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference | Benzinga

CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical compan...

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024 | Benzinga

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical compan...

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial re...
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metr...

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024 | Benzinga

CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical com...

Spero Therapeutics to Present at Cowen's 44th Annual Healthcare Conference | Benzinga

CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO) (Spero), a multi-asset clinical-stage biopharmaceuti...
5 Value Stocks In The Healthcare Sector | Benzinga

Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indi...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Spero Therapeutics Inc. (NASDAQ: SPRO) | Benzinga

NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that it has commenced an investigation of Spero Therapeutics Inc. (NA...

Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023 | Benzinga

CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical comp...
Previous 10 Next 10